BR8106137A - Polipeptidio sequencia de dna veiculo de expressao microbiiana copiavel plasmidio microorganismo composicao extrato bacteriano composicao farmaceutica cultura de celulas microbianas aplicacao de um interferon e processos de producaode alguns desses itens - Google Patents

Polipeptidio sequencia de dna veiculo de expressao microbiiana copiavel plasmidio microorganismo composicao extrato bacteriano composicao farmaceutica cultura de celulas microbianas aplicacao de um interferon e processos de producaode alguns desses itens

Info

Publication number
BR8106137A
BR8106137A BR8106137A BR8106137A BR8106137A BR 8106137 A BR8106137 A BR 8106137A BR 8106137 A BR8106137 A BR 8106137A BR 8106137 A BR8106137 A BR 8106137A BR 8106137 A BR8106137 A BR 8106137A
Authority
BR
Brazil
Prior art keywords
polypeptidy
plasmidio
microbiian
copyable
someone
Prior art date
Application number
BR8106137A
Other languages
English (en)
Inventor
R Crea
Norman Goeddel D Van
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26886463&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR8106137(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of BR8106137A publication Critical patent/BR8106137A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR8106137A 1980-09-25 1981-09-24 Polipeptidio sequencia de dna veiculo de expressao microbiiana copiavel plasmidio microorganismo composicao extrato bacteriano composicao farmaceutica cultura de celulas microbianas aplicacao de um interferon e processos de producaode alguns desses itens BR8106137A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19079980A 1980-09-25 1980-09-25
US29189281A 1981-08-11 1981-08-11

Publications (1)

Publication Number Publication Date
BR8106137A true BR8106137A (pt) 1982-06-15

Family

ID=26886463

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8106137A BR8106137A (pt) 1980-09-25 1981-09-24 Polipeptidio sequencia de dna veiculo de expressao microbiiana copiavel plasmidio microorganismo composicao extrato bacteriano composicao farmaceutica cultura de celulas microbianas aplicacao de um interferon e processos de producaode alguns desses itens

Country Status (33)

Country Link
US (1) US5460811A (pt)
EP (1) EP0048970A3 (pt)
AT (1) AT380694B (pt)
AU (1) AU582110B2 (pt)
BR (1) BR8106137A (pt)
CA (1) CA1341569C (pt)
CH (2) CH656388A5 (pt)
DD (3) DD209652A5 (pt)
DE (1) DE3138096A1 (pt)
DK (1) DK423381A (pt)
ES (3) ES8307297A1 (pt)
FI (1) FI812993L (pt)
FR (1) FR2490675B1 (pt)
GB (1) GB2098996B (pt)
GR (1) GR81946B (pt)
HK (1) HK43686A (pt)
IE (1) IE51679B1 (pt)
IL (1) IL63916A0 (pt)
IT (1) IT1139487B (pt)
KE (1) KE3630A (pt)
LU (1) LU83648A1 (pt)
MC (1) MC1423A1 (pt)
MT (1) MTP900B (pt)
MY (1) MY8600634A (pt)
NL (1) NL8104400A (pt)
NO (1) NO813248L (pt)
NZ (1) NZ198445A (pt)
OA (1) OA06908A (pt)
PL (1) PL233194A1 (pt)
PT (1) PT73728B (pt)
SE (1) SE8105657L (pt)
YU (1) YU44835B (pt)
ZW (1) ZW23981A1 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
IN156128B (pt) * 1980-04-03 1985-05-18 Biogen Nv
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
DK489481A (da) * 1980-11-10 1982-05-11 Searle & Co Plasmidvektor og frmgangsmaade til fremstilling deraf
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
JPS58110600A (ja) * 1981-12-25 1983-07-01 Kyowa Hakko Kogyo Co Ltd ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
AU575301B2 (en) * 1982-10-08 1988-07-28 Juridical Foundation, Japanese Foundation For Cancer Research Novel vector
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4599197A (en) * 1982-12-22 1986-07-08 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
GR79124B (pt) * 1982-12-22 1984-10-02 Genentech Inc
US5683688A (en) 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
GB8414354D0 (en) * 1984-06-05 1984-07-11 Biogen Nv Purifying protein
US5231176A (en) * 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
ATE47864T1 (de) * 1984-08-27 1989-11-15 Genentech Inc Verschiedenartige familie von menschlichen leukozyten-interferonen, zusammensetzungen, die diese enthalten, verfahren zu ihrer herstellung, sowie dna und transfektierte wirte hierfuer.
US4680262A (en) * 1984-10-05 1987-07-14 Genentech, Inc. Periplasmic protein recovery
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
EP0237019A3 (en) * 1986-03-14 1988-03-09 Toray Industries, Inc. Interferon conjugate and production thereof using recombinant gene
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US6713609B1 (en) * 1996-07-16 2004-03-30 Genentech, Inc. Monoclonal antibodies to type I interferon receptor
JP3576819B2 (ja) 1997-07-30 2004-10-13 キヤノン株式会社 情報処理装置及び印刷制御方法並びに記憶媒体
US20030018174A1 (en) * 1997-10-06 2003-01-23 Genentech, Inc. Monoclonal antibodies to IFNAR2
EP1165835A2 (en) 1999-03-24 2002-01-02 Serono Genetics Institute S.A. GENOMIC SEQUENCE OF THE $i(PURH) GENE AND $i(PURH)-RELATED BIALLELIC MARKERS
WO2001079480A1 (en) 2000-04-12 2001-10-25 Human Genome Sciences, Inc. Albumin fusion proteins
US7544357B2 (en) * 2001-01-09 2009-06-09 Baylor Research Institute Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
EP1997829A1 (en) 2001-12-21 2008-12-03 Human Genome Sciences, Inc. Albumin fusion proteins
KR101271635B1 (ko) * 2001-12-21 2013-06-12 휴먼 게놈 사이언시즈, 인코포레이티드 알부민 융합 단백질
PT1667708E (pt) 2002-12-26 2012-09-14 Mountain View Pharmaceuticals Conjugados de interferão-beta-1b e polietileno glicol apresentando uma potência biológica in vitro aumentada
EA013535B1 (ru) * 2002-12-26 2010-06-30 Маунтин Вью Фамэсьютикэлс, Инк. Полимерный конъюгат биоактивного компонента (варианты), способ его получения и использования, фармацевтические продукты на его основе
EP1594530A4 (en) 2003-01-22 2006-10-11 Human Genome Sciences Inc HYBRID PROTEINS OF ALBUMIN
CN103755800B (zh) 2004-02-02 2016-02-24 Ambrx公司 经修饰的人类生长激素多肽与其用途
JP2008543335A (ja) * 2005-06-22 2008-12-04 ジェネンテック・インコーポレーテッド Ｉｆｎａｒ２を標的とするための方法と組成物
MX2010008632A (es) 2008-02-08 2010-08-30 Ambrx Inc Leptina-polipeptidos modificados y sus usos.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1215921A (en) * 1977-11-08 1986-12-30 Arthur D. Riggs Method and means for microbial polypeptide expression
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
IN150740B (pt) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4332892A (en) * 1979-01-15 1982-06-01 President And Fellows Of Harvard College Protein synthesis
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
ZA803943B (en) * 1979-07-31 1981-06-24 Hoffmann La Roche Homogeneous fibroblast interferon and method for manufacture thereof
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4418149A (en) * 1980-01-10 1983-11-29 President And Fellows Of Harvard College Fused hybrid gene
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
GB2068970B (en) * 1980-02-06 1983-06-22 Searle & Co Recombinant dna technique for the preparation of a protein resembling human interferon
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
IN156128B (pt) * 1980-04-03 1985-05-18 Biogen Nv
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
US4874702A (en) * 1980-09-08 1989-10-17 Biogen, Inc. Vectors and methods for making such vectors and for expressive cloned genes

Also Published As

Publication number Publication date
KE3630A (en) 1986-05-16
NL8104400A (nl) 1982-04-16
AU7564981A (en) 1982-04-01
AU582110B2 (en) 1989-03-16
DD202085A5 (de) 1983-08-24
GB2098996A (en) 1982-12-01
CH656388A5 (de) 1986-06-30
DD209652A5 (de) 1984-05-16
DD209477A5 (de) 1984-05-09
YU229781A (en) 1984-02-29
NZ198445A (en) 1984-05-31
CH651309A5 (de) 1985-09-13
YU44835B (en) 1991-04-30
FR2490675B1 (fr) 1985-11-15
IE812224L (en) 1982-03-25
PT73728A (en) 1981-10-01
GB2098996B (en) 1985-02-06
DE3138096A1 (de) 1982-06-09
DK423381A (da) 1982-03-26
FI812993L (fi) 1982-03-26
NO813248L (no) 1982-03-26
HK43686A (en) 1986-06-20
IE51679B1 (en) 1987-02-04
EP0048970A3 (en) 1982-08-18
IT8124109A0 (it) 1981-09-23
ES505742A0 (es) 1983-07-01
ATA410381A (de) 1985-11-15
GR81946B (pt) 1984-12-12
CA1341569C (en) 2008-03-25
ES515033A0 (es) 1983-06-01
AT380694B (de) 1986-06-25
SE8105657L (sv) 1982-03-26
US5460811A (en) 1995-10-24
ES8306324A1 (es) 1983-06-01
LU83648A1 (de) 1983-06-08
IT1139487B (it) 1986-09-24
ES8307297A1 (es) 1983-07-01
MY8600634A (en) 1986-12-31
FR2490675A1 (fr) 1982-03-26
EP0048970A2 (en) 1982-04-07
MC1423A1 (fr) 1982-10-18
PT73728B (en) 1984-05-08
MTP900B (en) 1985-02-28
IL63916A0 (en) 1981-12-31
PL233194A1 (en) 1983-07-18
OA06908A (fr) 1983-05-31
ES515032A0 (es) 1983-06-01
ZW23981A1 (en) 1982-04-28
ES8306325A1 (es) 1983-06-01

Similar Documents

Publication Publication Date Title
BR8106137A (pt) Polipeptidio sequencia de dna veiculo de expressao microbiiana copiavel plasmidio microorganismo composicao extrato bacteriano composicao farmaceutica cultura de celulas microbianas aplicacao de um interferon e processos de producaode alguns desses itens
BR8104189A (pt) Polipeptideos,sequencias de dna,veiculo de expressao,plasmideo,microorganismo,bacteria,linhagem de e.coli,composicao contendo polipeptideo,extrato,composicao farmaceutica,cultura de celulas microbiais,usos de alguns desses itens,e processos de preparacao
FR2505835B1 (fr) Nouvelles 1,2-diaminocyclobutene-3,4-diones, leur procede de preparation et composition pharmaceutique les contenant
BR8700045A (pt) Nitrilase bacteriana,hospedeiro bacteriano,composicao bacteria hospedeira,cassete de expressao,plasmidio,sequencia de dna,celula de planta e planta
NZ210300A (en) Preparation of hyaluronic acid from bacterial culture
IE812478L (en) 3-(p-ALKYLSULFONYLPHENYL)-OXAZOLIDINONE DERIVATIVES
BE880201A (fr) Proteines purifiees, procede de preparation et compositions pharmaceutiques les contenant
IT8168566A0 (it) Complesso antibiotico procedimento per la sua preparazione composizione farmaceutica contenente tale complesso e microorganismo per l attuazione di tale procedimento
MA23490A1 (fr) Derives de lipopeptide, procede pour leur preparation, composition les contenant et leur utilisation .
BR8205954A (pt) Sequencia de dna,plasmidio recombinante,cultura bacteriana e microorganismos
LU80795A1 (fr) Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant
IE850912L (en) 9a-AZA-9a HOMOERYTHROMYCIN DERIVATIVES.
AR226964A1 (es) Portas de caldo de cultivo preparados para la determinacion cualitativa y cuantitativa de microorganismos
DE69638329D1 (de) Oligonukleotide zur Detektion von Salmonella
JPS5545400A (en) Staining composition and method of bacteria
DE3279841D1 (en) Method of culturing microbes belonging to the genus bordetella and culture medium
FR2568892B1 (fr) Nouvel antibiotique sandramycine, procede de preparation de celui-ci, culture biologiquement pure du micro-organisme nocardioides sp, atcc no 39419, et composition pharmaceutique contenant la sandramycine
McBride et al. The role of outer membrane proteins in the survival of Neisseria gonorrhoeae P9 within guinea-pig subcutaneous chambers
BR9400600A (pt) Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos
JPS5786289A (en) Nutrient liquid composition and culturing of microorganism in hydrophobic medium by using same
FR2509139B1 (fr) Isolement de proteine microbienne d'une teneur reduite en acides nucleiques
AU5044390A (en) Microbiological chiral reduction of carbonyl groups and novel microorganism
ZA863219B (en) Novel anthelmintic fermentation products of microorganism
ATE4637T1 (de) Pentadecapeptid, verfahren zu seiner herstellung und immunisierendes mittel.
AU591290B2 (en) Rapid detection of n. gonorrhoeae without culture

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: C12N 15/10 (2006.01), C07K 14/565 (2006.0